Literature DB >> 6159349

Synthesis of (2'-5')(A)n from ATP. Characteristics of the reaction catalyzed by (2'-5')(A)n synthetase purified from mouse Ehrlich ascites tumor cells treated with interferon.

H Samanta, J P Dougherty, P Lengyel.   

Abstract

The treatment of Ehrlich ascites tumor cells with mouse interferon increases the level of the latent enzyme (2'-5')(A)n synthetase. If activated by double-stranded RNA, this catalyzes the synthesis from ATP of a series of 2'-5'-oligoadenylates: (2'-5')(A)n where n extends from 2 to about 15. We isolated (2'-5')(A)n synthetase in a homogeneous state. In the presence of double-stranded RNA, the purified enzyme can convert the large majority (about 97%) of the ATP into (2'-5')(A)n and pyrophosphate, although it does not cleave the pyrophosphate. The stoichiometry of the reaction can be formulated as: (n + I) ATP leads to (2'-5') pppA(pA)n + n pyrophosphate. Added pyrophosphate does not inhibit the synthesis of (2'-5')(A)n. The extent of the reverse reaction, i.e. the pyrophosphorolysis of (2'-5')(A)n, was below the level of detection under our conditions. The affinity of the enzyme for ATP is low: the rate of the reaction increases by about 10% when the concentration of ATP is increased from 5 mM to 10 mM. The optimal concentration of double-stranded RNA increases with the concentration of the enzyme. As tested at 0.4, 2, and 10 micrograms/ml of enzyme concentrations, close to maximal (2'-5')(A)n synthesis can be obtained if reovirus double-stranded RNA or poly(I) . poly(C) are used at about half the concentration (in w/v) of the enzyme. The plot of the reaction rate versus enzyme concentration is sigmoidal. It remains to be seen if this reflects on a cooperative behavior of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6159349

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  (2'-5')Oligoadenylate in rat liver: modulation after partial hepatectomy.

Authors:  M Etienne-Smekens; P Vandenbussche; J Content; J E Dumont
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

2.  5'-O-Monophosphoryladenylyl(2' goes to 5')adenylyl(2' goes to 5')adenosine is an antagonist of the action of 5'-O-triphosphoryladenylyl-(2' goes to 5')adenylyl(2' goes to 5')adenosine and double-stranded RNA.

Authors:  P F Torrence; J Imai; M I Johnston
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

3.  2',5'-linked oligo-3'-deoxyribonucleoside phosphorothioate chimeras: thermal stability and antisense inhibition of gene expression.

Authors:  P Bhan; A Bhan; M Hong; J G Hartwell; J M Saunders; G D Hoke
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

4.  The murine 2-5A synthetase locus: three distinct transcripts from two linked genes.

Authors:  M N Rutherford; A Kumar; A Nissim; J Chebath; B R Williams
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

5.  Interferon action: binding of viral RNA to the 40-kilodalton 2'-5'-oligoadenylate synthetase in interferon-treated HeLa cells infected with encephalomyocarditis virus.

Authors:  G Gribaudo; D Lembo; G Cavallo; S Landolfo; P Lengyel
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

6.  Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma.

Authors:  Y Ozaki; M P Edelstein; D S Duch
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

7.  Accumulation of 2',5'-oligoadenylates in encephalomyocarditis virus-infected mice.

Authors:  W G Hearl; M I Johnston
Journal:  J Virol       Date:  1987-05       Impact factor: 5.103

8.  Structure of two forms of the interferon-induced (2'-5') oligo A synthetase of human cells based on cDNAs and gene sequences.

Authors:  P Benech; Y Mory; M Revel; J Chebath
Journal:  EMBO J       Date:  1985-09       Impact factor: 11.598

Review 9.  The 2-5A system: modulation of viral and cellular processes through acceleration of RNA degradation.

Authors:  M R Player; P F Torrence
Journal:  Pharmacol Ther       Date:  1998-05       Impact factor: 12.310

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.